These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16371301)

  • 21. Vaginal distribution of miconazole nitrate suspension from administration of a single vaginal insert.
    Barnhart K; Pretorius ES; Marunich R; Hummel A
    J Reprod Med; 2004 Feb; 49(2):83-8. PubMed ID: 15018434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
    Aranha CC; Gupta SM; Reddy KV
    Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Sci; 2016 Oct; 93():410-8. PubMed ID: 27559026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB; Perfect MM; Auslander BA; Devellis RF; Rosenthal SL
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products.
    Ayehunie S; Cannon C; Lamore S; Kubilus J; Anderson DJ; Pudney J; Klausner M
    Toxicol In Vitro; 2006 Aug; 20(5):689-98. PubMed ID: 16309879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ; Guzman E; Hazrati E; Kasowitz A; Cheshenko N; Wallenstein S; Cole AL; Cole AM; Profy AT; Wira CR; Hogarty K; Herold BC
    AIDS; 2007 Feb; 21(4):467-76. PubMed ID: 17301565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of ambulation on vaginal distribution of miconazole nitrate (1200 mg).
    Menon S; Izquierdo A; Rosen M; Hummel A; Barnhart K
    J Womens Health (Larchmt); 2007 Jun; 16(5):703-6. PubMed ID: 17627405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging.
    Barnhart K; Pretorius ES; Stolpen A; Malamud D
    Fertil Steril; 2001 Jul; 76(1):189-95. PubMed ID: 11438341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
    Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
    J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
    van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
    Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.
    Smith-McCune KK; Tuveson JL; Rubin MM; Da Costa MM; Darragh TM; Shiboski SC; Van Der Pol B; Moscicki AB; Palefsky JM; Sawaya GF
    J Low Genit Tract Dis; 2006 Oct; 10(4):213-8. PubMed ID: 17012985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of microbicide gel adherence monitoring methods.
    Moench TR; O'Hanlon DE; Cone RA
    Sex Transm Dis; 2012 May; 39(5):335-40. PubMed ID: 22504592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of primary vaginal carcinoma.
    Taylor MB; Dugar N; Davidson SE; Carrington BM
    Clin Radiol; 2007 Jun; 62(6):549-55. PubMed ID: 17467392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
    Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. After microbicide failures, hope that antiviral approach will gel.
    Padma TV
    Nat Med; 2008 Apr; 14(4):354. PubMed ID: 18391925
    [No Abstract]   [Full Text] [Related]  

  • 38. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.
    Pentlicky S; Rosen M; Coffey PS; Kilbourne-Brook M; Shaunik A; Schreiber CA; Barnhart K
    Contraception; 2013 Feb; 87(2):187-92. PubMed ID: 22898358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal drug distribution modeling.
    Katz DF; Yuan A; Gao Y
    Adv Drug Deliv Rev; 2015 Sep; 92():2-13. PubMed ID: 25933938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS; Ngoh N; Roddy R; Lai JJ; Linton K; Mauck C
    Contraception; 2007 Sep; 76(3):245-9. PubMed ID: 17707724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.